BioCentury
ARTICLE | Company News

Zonagen says Vasomax MAA to be withdrawn

April 29, 2002 7:00 AM UTC

ZONA said after market close that partner Schering-Plough (SGP) will withdraw an MAA for U.K. marketing approval of ZONA's Vasomax oral phentolamine to treat erectile dysfunction. ZONA said the decision follows comments on the submission by the U.K.'s Committee on Safety and Medicines. ...